Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Appointed director
Director departure

NANOMIX Corp (BTHE) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/20/2015 4/A PLATT DAVID (CEO and Chairman) has filed a Form 4 on Boston Therapeutics, Inc.
Txns: Bought 500 shares @ $0.5999, valued at $300
Bought 100 shares @ $0.5999, valued at $60

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy